Elizabeth Mormino, PhD

Dr. Beth Mormino completed a PhD in Neuroscience at UC Berkeley in the laboratory of Dr. William Jagust, where she performed some of the initial studies applying Amyloid PET with the tracer PIB to clinically normal older individuals. This initial work provided evidence that the pathophysiological processes of Alzheimer’s disease begin years before clinical symptoms and are associated with subtle changes to brain regions critical for memory. During her postdoctoral fellowship with Drs. Reisa Sperling and Keith Johnson at Massachusetts General Hospital, she used multimodal imaging techniques to understand longitudinal cognitive changes among individuals classified as preclinical Alzheimer's. Dr. Mormino joined Stanford University in the department of Neurology and Neurological Sciences in 2017. Her research program focuses on combining imaging, fluid biomarkers and genetics to predict cognitive trajectories over time in Alzheimers, dementia with Lewy bodies and Parkinson's, and the integration of novel PET scans to better understand human aging and neurodegenerative diseases.